La demência infantil é um termo clássico em neurologia pediátrica, que tem tentado tornar-se mais operacional através do conceito de PIND (deterioração intelectual e neurológica progressiva), con el que se trata de englobar todos los síndromes neurodegenerativos de la infancia. Este concepto incluye:

  • Presença de regressão do desenvolvimento (perda das capacidades intelectuais e aprendizagens já estabelecidas),.
  • Progressiva (não é autolimitado no tempo, mas é persistente até que a criança perca todas as suas habilidades, mesmo as mais básicas, como deambulação ou continência esfincteriana).
  • Generalizada (não afeta um único domínio cognitivo ou do desenvolvimento).
  • Aparecimento de sintomas e sinais neurológicos associados, evidenciáveis através da exploração clínica (transtorno oculomotor, piramidalismo, ataxia, transtornos do movimento, epilepsia).

Existem testes de rastreamento direcionado para descartar algumas destas doenças, com o objetivo de obter um diagnóstico precoce e antecipar a evolução catastrófica que apresentam.

Critérios diagnósticos de PIND

Definição de caso – deterioração intelectual e neurológica progressiva (registro UK PIND).

Any child (under 16y of age at onset of symptoms) who fulfils all of the following three criteria: Progressive deterioration for more than 3mo; Loss of already attained intellectual or developmental abilities; and Development of abnormal neurological signs
Excluindo
Perda intelectual estática (ex: após encefalite, traumatismo craniano ou quase afogamento)
Incluindo
Crianças que preencham a definição de caso, mesmo que tenham sido feitos diagnósticos neurológicos específicos
Distúrbios metabólicos que levam à deterioração neurológica
Distúrbios convulsivos se associados a deterioração progressiva
Crianças que foram diagnosticadas com distúrbios neurodegenerativos, mas que ainda não desenvolveram sintomas
Relato restrito a casos vistos no último mês, mas incluindo aqueles cuja condição começou anteriormente (ou seja, incluindo "casos antigos" de crianças em acompanhamento, se vistas naquele mês)
19955111 {19955111:CLQYR5RR} 1 vancouver 50 default 3116 https://neuropediatoolkit.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22CLQYR5RR%22%2C%22library%22%3A%7B%22id%22%3A19955111%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Verity%20et%20al.%22%2C%22parsedDate%22%3A%222021-03%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BVerity%20C%2C%20Baker%20E%2C%20Maunder%20P%2C%20Pal%20S%2C%20Winstone%20AM.%20Differential%20diagnosis%20of%20progressive%20intellectual%20and%20neurological%20deterioration%20in%20children.%20Dev%20Med%20Child%20Neurol%20%5BInternet%5D.%202021%20Mar%20%5Bcited%202022%20Oct%2015%5D%3B63%283%29%3A287%26%23x2013%3B94.%20Available%20from%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC7891454%5C%2F%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC7891454%5C%2F%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Differential%20diagnosis%20of%20progressive%20intellectual%20and%20neurological%20deterioration%20in%20children%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Verity%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elaine%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Polly%22%2C%22lastName%22%3A%22Maunder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suvankar%22%2C%22lastName%22%3A%22Pal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20Marie%22%2C%22lastName%22%3A%22Winstone%22%7D%5D%2C%22abstractNote%22%3A%22The%20prevalence%20of%20diseases%20causing%20childhood%20progressive%20intellectual%20and%20neurological%20deterioration%20in%20the%20UK%20is%20low%20%28approximately%200.1%5C%2F1000%20live%20births%29.There%20were%20more%20than%20220%20different%20disorders%2C%20mainly%20genetically%20determined.The%20majority%20of%20disorders%20presented%20early%20in%20childhood%3A%2081%25%20before%20the%20age%20of%205%5Cu00a0years.There%20were%20similarities%20in%20the%20disease%20spectrum%20in%20White%20and%20Pakistani%20children.%5Cn%2C%20Video%20Podcast%3A%20https%3A%5C%2F%5C%2Fyoutu.be%5C%2FQbUG-ZVJLHc%5Cn%2C%20This%20article%20is%20commented%20on%20by%20van%20Karnebeek%20on%20page%20243%20of%20this%20issue.%22%2C%22date%22%3A%222021-3%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1111%5C%2Fdmcn.14691%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC7891454%5C%2F%22%2C%22PMID%22%3A%2232970345%22%2C%22PMCID%22%3A%22PMC7891454%22%2C%22ISSN%22%3A%220012-1622%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%22VV74KMGP%22%5D%2C%22dateModified%22%3A%222026-05-09T06%3A10%3A39Z%22%7D%7D%5D%7D
1.
Verity C, Baker E, Maunder P, Pal S, Winstone AM. Differential diagnosis of progressive intellectual and neurological deterioration in children. Dev Med Child Neurol [Internet]. 2021 Mar [cited 2022 Oct 15];63(3):287–94. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891454/
Pseudorregressão.

É necessário diferenciar a verdadeira regressão da pseudorregressão.

  • Pseudorregressão nas encefalopatias estáticas: Evolução natural das encefalopatias estáticas, que podem apresentar um agravamento relacionado com a etapa do desenvolvimento pós-puberal, como consequência das alterações biológicas que ocorrem no organismo com a chegada da idade adulta (piora da espasticidade).
  • Regressão autista. É característica em crianças com TEA, surge entre os 18 e os 24 meses, afeta principalmente a linguagem, mas não apresenta uma progressão posterior.
  • Pseudorregressão psicogênicaTrata-se da perda de marcos do desenvolvimento já adquiridos (como o controle esfincteriano) habitual em crianças pequenas, como consequência de mudanças no ambiente (nascimento de um irmão, etc.), transitória e com um gatilho emocional identificável.
Doenças que produzem PIND
Doenças lisossomais.
Doenças lisossomais que afetam o transporte e o metabolismo dos lípidos.

• Deficiência de saposina combinada (prosaposina)
• Doença de Farber
• Doença de Gaucher (tipo 2)
• Doença de Gaucher (tipo 3)
• Leucodistrofia de células globoides (doença de Krabbe)
• Gangliosidose GM1 (tipo 1 e 2)
• Gangliosidose GM2 – variante AB
• Gangliosidose GM2 (Doença de Tay-Sachs)
• Gangliosidose GM2 (doença de Sandhoff)
• Leucodistrofia metacromática
• Deficiência múltipla de sulfatase
• Doença de Niemann-Pick tipo A
• Doença de Niemann-Pick tipo C
• Deficiência de saposina A
• Deficiência de saposina B
• Deficiência de saposina C

Glicoproteinoses.

• Alfa-manosidose
• Deficiência de α-N-acetilgalactosaminidase (doença de Schindler (tipo I))
• Aspartilglucosaminúria (AGU)
• Beta-manosidose
• Fucosidose (tipo I e II)
• Galactosialidose (mutação na catepsina A)
• Mucolipidose tipo I (sialidose tipo II)
• Mucolipidose tipo II (doença de I-cell)
• Mucolipidose tipo IV

• MPS I (síndrome de Hurler)
• MPS II (síndrome de Hunter)
• MPS III (síndrome de Sanfilippo)
• MPS VII (Síndrome de Sly)

Outras doenças lisossomais.

• Lipofuscinoses ceroides neuronais (NCLs ou doença de Batten); 14 subtipos (exceto aqueles de início na idade adulta CLN 4, 11, 13)
• Doença de depósito de ácido siálico

Metabolismo dos lípidos.

• Abetalipoproteinemia
• Xantomatose cerebrotendinosa

Aminoacidopatias e doenças dos ácidos orgânicos.

• Doença de Canavan
• Deficiência de glutationa sintetase
• Encefalopatia da glicina / hiperglicinemia não cetótica
• Deficiência de holocarroxilase sintetase
• Deficiência de sulfito oxidase

Diagnóstico diferencial.
De acordo com os sintomas neurológicos.
Polioencefalopatias.
Leucoencefalopatias.
Corencefalopatias.
Espinocerebelopatias.
De acordo com a idade de início.
19955111 {19955111:ZJTIEEEK} 1 vancouver 50 default 3116 https://neuropediatoolkit.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ZJTIEEEK%22%2C%22library%22%3A%7B%22id%22%3A19955111%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mishra%22%2C%22parsedDate%22%3A%222018-07-17%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BMishra%20S.%20Approach%20to%20Neurodegenerative%20Disease%20in%20Children%3A%20A%20Short%20Review.%20PAPN%20%5BInternet%5D.%202018%20July%2017%20%5Bcited%202021%20July%2021%5D%3B1%285%29.%20Available%20from%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.lupinepublishers.com%5C%2Fpediatrics-neonatal-journal%5C%2Ffulltext%5C%2Fopenaccess-approach-to-neurodegenerative-disease-in-children-a-short-review.ID.000121.php%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.lupinepublishers.com%5C%2Fpediatrics-neonatal-journal%5C%2Ffulltext%5C%2Fopenaccess-approach-to-neurodegenerative-disease-in-children-a-short-review.ID.000121.php%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Approach%20to%20Neurodegenerative%20Disease%20in%20Children%3A%20A%20Short%20Review%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shubhankar%22%2C%22lastName%22%3A%22Mishra%22%7D%5D%2C%22abstractNote%22%3A%22Neurodegenerative%20disorders%20of%20childhood%20are%20complicated%20diseases%20with%20wide%20range%20of%20systematic%20involvement.%20These%20diseases%20often%20pose%20great%20challenge%20to%20clinicians%20in%20terms%20of%20diagnosis%20and%20management.%20The%20purpose%20of%20this%20article%20is%20to%20outline%20a%20systematic%20approach%20to%20a%20child%20presenting%20with%20suspected%20neurodevelopmental%20regression.%20Many%20inherited%20metabolic%20disorders%20present%20with%20neural%20regression.%20The%20clinical%20approach%20depends%20upon%20the%20age%20of%20presentation%2C%20site%20of%20involvement%20in%20brain.%20Sound%20clinical%20knowledge%20and%20better%20approach%20leads%20to%20early%20diagnosis%2C%20better%20management%20and%20above%20all%20genetic%20counselling.%20As%20the%20medical%20science%20is%20in%20the%20track%20of%20rapid%20progression%20several%20treatment%20modalities%20are%20in%20the%20pipeline%20for%20neurodegenerative%20syndromes%2C%20early%20diagnosis%20and%20referral%20to%20higher%20centres%20can%20bring%20a%20better%20future%20to%20the%20child.%22%2C%22date%22%3A%222018-7-17%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.32474%5C%2FPAPN.2018.01.000121%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.lupinepublishers.com%5C%2Fpediatrics-neonatal-journal%5C%2Ffulltext%5C%2Fopenaccess-approach-to-neurodegenerative-disease-in-children-a-short-review.ID.000121.php%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%2226374722%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22VV74KMGP%22%5D%2C%22dateModified%22%3A%222026-07-15T22%3A37%3A55Z%22%7D%7D%5D%7D
1.
Mishra S. Approach to Neurodegenerative Disease in Children: A Short Review. PAPN [Internet]. 2018 July 17 [cited 2021 July 21];1(5). Available from: https://www.lupinepublishers.com/pediatrics-neonatal-journal/fulltext/openaccess-approach-to-neurodegenerative-disease-in-children-a-short-review.ID.000121.php
Informação de sensibilização.

Demência infantil é uma página web dedicada à difusão e sensibilização destas doenças, com o objetivo de conscientizar a população e as autoridades sanitárias sobre a importância do investimento em investigação para o progresso dos tratamentos destas doenças devastadoras.